The most important financial indicators for the company Uroclinic Dr. Haşegan S.r.l. - Unique Identification Number 35547613:
sales in 2023 was
263.354
euro, registering a net profit of
196.969
euro and having an average number of
1
employees.
Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded.
In the last year of activity, the sales increased by 34.4%, from 196.581 euro in the year 2022, to 263.354 euro in 2023.
The Net Profit increased by 49.339 euro, from 148.079 euro in 2022, to 196.969 in the last year.
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Uroclinic Dr. Haşegan S.r.l. - CUI 35547613
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Fixed Assets
-
-
14.349
16.025
30.588
35.377
38.895
31.927
73.841
56.604
Current Assets
-
-
19.038
97.098
107.904
17.796
139.583
132.217
95.029
157.001
Inventories
-
-
0
0
0
0
0
0
0
0
Receivables
-
-
514
5.010
494
0
0
19.657
89.034
89.224
Cash
-
-
18.525
92.088
107.409
17.795
139.583
112.560
5.995
67.777
Shareholders Funds
-
-
30.894
111.959
137.086
51.673
174.938
159.687
162.205
211.052
Social Capital
-
-
45
44
43
42
41
40
41
40
Debts
-
-
2.493
1.165
1.406
1.499
3.541
4.457
6.665
2.554
Income in Advance
-
-
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
4.4821
Main CAEN
"8622 - 8622"
CAEN Financial Year
8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
157.001 euro in 2023 which includes Inventories of
0 euro, Receivables of
89.224 euro and cash availability of
67.777 euro.
The company's Equity was valued at
211.052 euro, while total Liabilities amounted to
2.554 euro.
Equity increased by 49.339 euro, from 162.205 euro in 2022, to 211.052 in 2023.
Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Uroclinic Dr. Haşegan S.r.l.